21.11.2016 • Topics

Millireactor in Production

Ehrfeld Mikrotechnik BTS designed, manufactured and supplied a MIPROWA...
Ehrfeld Mikrotechnik BTS designed, manufactured and supplied a MIPROWA production reactor for Shaoxing Eastlake Biochemical (China)

Ehrfeld Mikrotechnik BTS designed, manufactured and supplied a MIPROWA production reactor for Shaoxing Eastlake Biochemical (China) for a production capacity of up to 10,000 t/a. The MIPROWA millireactor with a throughput of about 1m3/h has a nominal width of 400 mm and a length of 7 m and contains about 150 rectangular reaction channels with exchangeable static mixers.

Shaoxing Eastlake Biochemical successfully launched the production plant in Shaoxing mid-September. The continuously operated millireactor replaces more than 20 batch reactors. The fast and strong exothermic reaction is of alkoxylation type. Decision for Miprowa technology was driven by achievable product quality, significantly improved yield, safety aspects and a short return on investment. Eastlake serves the global market segment of agrochemicals based on their active ingredients production.

Scale up started from lab scale by a transition of channel geometries from micrometer to millimeter scale. By this proceeding similar conditions could be achieved in lab scale as later in the channels of the production reactor. Furthermore conclusions could be drawn about the performance parameters of the reactor in production scale. Additional validation experiments in pilot scale with same channel geometries as in production were needed for testing real raw material behavior. Compared to established process technologies a much faster scale-up process could be realized.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read